![Melanoma Institute Australia on X: "Most patients with a thin melanoma have excellent prognosis, but not all. Thanks to a new online risk calculator developed by MIA clinicians can now calculate the Melanoma Institute Australia on X: "Most patients with a thin melanoma have excellent prognosis, but not all. Thanks to a new online risk calculator developed by MIA clinicians can now calculate the](https://pbs.twimg.com/media/EvsOlkuUYAU7ftd.jpg:large)
Melanoma Institute Australia on X: "Most patients with a thin melanoma have excellent prognosis, but not all. Thanks to a new online risk calculator developed by MIA clinicians can now calculate the
![Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram | Journal of Clinical Oncology Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2020/jco.2020.38.issue-24/jco.2020.38.issue-24/20200817/jco.2020.38.issue-24.largecover.jpg)
Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram | Journal of Clinical Oncology
![Frontiers | Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects Frontiers | Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects](https://www.frontiersin.org/files/Articles/642380/fmed-08-642380-HTML/image_m/fmed-08-642380-g001.jpg)
Frontiers | Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects
![Prediction of early-stage melanoma recurrence using clinical and histopathologic features | npj Precision Oncology Prediction of early-stage melanoma recurrence using clinical and histopathologic features | npj Precision Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41698-022-00321-4/MediaObjects/41698_2022_321_Fig2_HTML.png)
Prediction of early-stage melanoma recurrence using clinical and histopathologic features | npj Precision Oncology
![Frontiers | A Predictive Web-Based Nomogram for Elderly Patients Newly Diagnosed as Uveal Melanoma: A Population-Based Study Frontiers | A Predictive Web-Based Nomogram for Elderly Patients Newly Diagnosed as Uveal Melanoma: A Population-Based Study](https://www.frontiersin.org/files/MyHome%20Article%20Library/799083/799083_Thumb_400.jpg)
Frontiers | A Predictive Web-Based Nomogram for Elderly Patients Newly Diagnosed as Uveal Melanoma: A Population-Based Study
![Temporal Recurrence of Cutaneous Melanoma: Analysis of a Case Series | JCAD | The Journal of Clinical and Aesthetic Dermatology Temporal Recurrence of Cutaneous Melanoma: Analysis of a Case Series | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/Drummond-Lagev2.jpg)
Temporal Recurrence of Cutaneous Melanoma: Analysis of a Case Series | JCAD | The Journal of Clinical and Aesthetic Dermatology
![Online prediction tools for melanoma survival: A comparison - Dixon - 2023 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library Online prediction tools for melanoma survival: A comparison - Dixon - 2023 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/fc01198e-f340-4bab-aaff-64c2dbbc21f5/jdv19219-fig-0001-m.jpg)
Online prediction tools for melanoma survival: A comparison - Dixon - 2023 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library
![MelRisk: Using neutrophil-to-lymphocyte ratio to improve risk prediction models for metastatic cutaneous melanoma in the sentinel lymph node - ScienceDirect MelRisk: Using neutrophil-to-lymphocyte ratio to improve risk prediction models for metastatic cutaneous melanoma in the sentinel lymph node - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S174868152100629X-gr2.jpg)